Literature DB >> 6155970

Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.

R Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6155970      PMCID： PMC1601521          DOI： 10.1136/bmj.280.6225.1199

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  31 in total

1.  Prenatal diagnosis of spina bifida and anencephaly through maternal plasma-alpha-fetoprotein measurement.

Authors:  D J Brock; A E Bolton; J B Scrimgeour
Journal:  Lancet       Date:  1974-04-27       Impact factor: 79.321

2.  Prenatal diagnosis of spina bifida and anencephaly by maternal serum-alpha-fetoprotein measurement. A controlled study.

Authors:  N J Wald; D J Brock; J Bonnar
Journal:  Lancet       Date:  1974-04-27       Impact factor: 79.321

3.  Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly.

Authors:  R Harris; R F Jennison; A J Barson; K M Laurence; E Ruoslahti; M Seppälä
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321

4.  Prenatal diagnosis of anencephaly through maternal serum-alphafetoprotein measurement.

Authors:  D J Brock; A E Bolton; J M Monaghan
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

5.  Early termination of anencephalic pregnancy after detection by raised alpha-fetoprotein levels.

Authors:  M J Seller; S Campbell; T M Coltart; J D Singer
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

6.  Raised alpha-fetoprotein in maternal serum with anencephalic pregnancy.

Authors:  A E Leek; C F Ruoss; M J Kitau; T Chard
Journal:  Lancet       Date:  1973-08-18       Impact factor: 79.321

7.  Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.

Authors:  D J Brock; R G Sutcliffe
Journal:  Lancet       Date:  1972-07-29       Impact factor: 79.321

8.  Early prenatal diagnosis of anencephaly.

Authors:  D J Brock; J B Scrimgeour
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

9.  Alpha fetoprotein in maternal serum: a new marker for detection of fetal distress and intrauterine death.

Authors:  M Seppälä; E Ruoslahti
Journal:  Am J Obstet Gynecol       Date:  1973-01-01       Impact factor: 8.661

10.  Alpha-fetoprotein in normal and pregnancy sera.

Authors:  M Seppälä; E Ruoslahti
Journal:  Lancet       Date:  1972-02-12       Impact factor: 79.321
View more
  5 in total

Review 1.  New uncertainties in prenatal screening for neural tube defect.

Authors:  R Harris; A P Read
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

2.  Prevention of neural tube defects in an urban health district.

Authors:  D Watson; M Pow; A Ellam; K Costeloe
Journal:  J Epidemiol Community Health       Date:  1983-09       Impact factor: 3.710

3.  Measuring the benefits of screening for open neural tube defects.

Authors:  J B Henderson
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

4.  Distress associated with prenatal screening for fetal abnormality.

Authors:  Marci Lobel; Lynette Dias; Bruce A Meyer
Journal:  J Behav Med       Date:  2005-02

5.  Making birth defects 'preventable': pre-conceptional vitamin supplements and the politics of risk reduction.

Authors:  Salim Al-Gailani
Journal:  Stud Hist Philos Biol Biomed Sci       Date:  2013-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.